Femasys

View the org chart displaying its 20 main executives

Most searched biographies at Femasys

• Kathy Lee-Sepsick, Director, President and Chief Executive Officer
• Wendy Perrow, Director
• Edward Uzialko, Director

Popular executive movements at Femasys

• Richard Spector has joined the company as Chief Commercial Officer  (posted on February 7 2024).

Create your alert
to follow the executive moves at Femasys.

Femasys has 986 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).

Popular M&A news in Medical Equipment

• Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
• Johnson & Johnson has announced the acquisition of Shockwave Medical  (posted on April 6 2024).
• Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).

Popular contacts in Medical Equipment

• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific
• Don Abbey - Executive Vice President, Global Business Services, Information Technology, Quality and Regulatory Affairs at DexCom
• Robert Rosenthal - Director at Bruker

Learn more about the Medical Equipment industry >

Press releases by Femasys

• Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
• Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
• Page Not Found
• Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
• Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
• Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
• Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
• Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
• Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
• Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
• View more press releases Close

Social media about Femasys

• Femasys on Wikipedia, Google News & Yahoo Finance
• Femasys on LinkedIn, Twitter & YouTube

Contact by email its executives including Kathy Lee-Sepsick

Call Femasys at +1 770...

View the org chart

Register to receive your alert

Report an error